eFFECTOR Therapeutics Inc (NASDAQ: EFTR) Shocks Wall Street This Week With A -15.20% Stock Price Decline
eFFECTOR Therapeutics Inc (NASDAQ:EFTR) has a beta value of 0.75 and has seen 2.38 million shares traded in the last trading session. The company, currently